|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130.36 USD | +1.26% |
|
+0.85% | -4.40% |
| 07/07 | RBC Raises Price Target on Neurocrine Biosciences to $146 From $145, Keeps Outperform Rating | MT |
| 01/07 | Neurocrine Biosciences, Inc.(NasdaqGS:NBIX) added to Russell Midcap Value Index | CI |
Transcripts
Search
23/06 | ||
22/05 | ||
13/05 | ||
18/03 | ||
11/03 | ||
04/03 | ||
07/02 | ||
13/01 | ||
05/12 | ||
03/12 | ||
19/11 | ||
18/11 | ||
13/11 | ||
30/24/30 | ||
26/24/26 | ||
18/24/18 | ||
05/24/05 | ||
05/24/05 | ||
28/24/28 | ||
15/24/15 | ||
01/24/01 | ||
13/24/13 | ||
06/24/06 | ||
14/24/14 | ||
01/24/01 |
No results for this search
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition